Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
clinical trials
ipo
5
×
life sciences
national blog main
sanofi
5
×
boston top stories
national top stories
san francisco blog main
san francisco top stories
cancer drugs
fda
new york blog main
new york top stories
abbvie
allergan
boulder/denver blog main
boulder/denver top stories
crispr
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
revolution medicines
san diego blog main
san diego top stories
san francisco
schrödinger
seattle blog main
seattle top stories
startups
What
ipo
medicines
bio
cancer
proteins
research
revolution
roundup
acquisitions
announced
black
cancer’s
ceo
collabs
companies
company’s
continue
course
covid
daniel
deal
debut
despite
development
diamond
diamond’s
discover
disease
drug
experimental
family
frontiers
gilead
gilead’s
growing
handiwork
hardest
help
helped
hit
Language
unset
5
×
Current search:
ipo
×
unset
×
sanofi
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline